Cancer Letters
Volume 226, Issue 1 , Pages 77-84 , 8 August 2005

An association of DNMT3b protein expression with P16INK4a promoter hypermethylation in non-smoking female lung cancer with human papillomavirus infection

  • Torng-Sen Lin

      Affiliations

    • Institute of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd, Taichung, Taiwan, ROC
    • Department of Surgery, Changhua Christian Hospital, Taichung, Taiwan, ROC
  • ,
  • Huei Lee

      Affiliations

    • Institute of Medical and Molecular Toxicology, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd, Taichung, Taiwan, ROC
  • ,
  • Ruei-A Chen

      Affiliations

    • Department of Surgery, Changhua Christian Hospital, Taichung, Taiwan, ROC
  • ,
  • Ming-Lin Ho

      Affiliations

    • Department of Internal Medicine, Changhua Christian Hospital, Taichung, Taiwan, ROC
  • ,
  • Chia-Yu Lin

      Affiliations

    • Department of Medicine, Zhejiang University, Zhejiang Province, People's Republic of China
  • ,
  • Ya-Hui Chen

      Affiliations

    • Department of Surgery, Changhua Christian Hospital, Taichung, Taiwan, ROC
  • ,
  • Yi Yu Tsai

      Affiliations

    • Institute of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd, Taichung, Taiwan, ROC
    • Department of Ophthalmology, China Medical University Hospital, Taichung, Taiwan, ROC
  • ,
  • Ming-Chih Chou

      Affiliations

    • Institute of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd, Taichung, Taiwan, ROC
    • Department of Thoracic Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan, ROC
  • ,
  • Ya-Wen Cheng

      Affiliations

    • Institute of Medicine, Chung Shan Medical University, No. 110, Sec. 1, Chien-Kuo N. Rd, Taichung, Taiwan, ROC
    • Corresponding Author InformationCorresponding author. Tel.: +886 4 24730022 11605; fax: +886 4 24723229.

Received 25 October 2004 ,Revised 8 December 2004 ,Accepted 13 December 2004.

References 

  1. Fearon E. Tumor suppressor genes. In:  Vogelstein B,  Kinzler KW editor. The Genetic Basis of Human Cancer. New York: McGraw-Hill Health Professions Division; 1998;p. 229–240
  2. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002;3:415–428
  3. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21:5427–5440
  4. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J. Natl Cancer Inst. 2000;92:1511–1516
  5. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 2001;6:1249–1255
  6. Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, et al. O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. Clin. Cancer Res. 2003;9:223–227
  7. Bestor TH. The DNA methyltransferases of mammals. Hum. Mol. Genet. 2000;9:2395–2402
  8. Robertson KD. DNA methylation methyltransferases, and cancer. Oncogene. 2001;20:3139–3155
  9. zur Hausen H. Papillomaviruses in human cancers. Proc. Assoc. Am. Phys. 1999;111:581–587
  10. Rickinson AB, Kieff E. Epstein–Bar virus. In:  Knipe DM,  Howley PM editor. Fields Virology. fourth ed.. Philadelphia, PA: Lippincott Williams & Wilkins Press; 2001;p. 2575–2627
  11. Raab-Traub N. Pathogenesis of Epstein–Barr virus and its associated malignancies. Semin. Virol. 1996;7:305–313
  12. Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr. Opin. Oncol. 2001;13:183–188
  13. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2001;344:1125–1131
  14. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int. J. Cancer. 2001;93:232–235
  15. Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, et al. Prevelance of mucosotropic human papillomaviruses in squamouscell carcinoma of the head and neck. Int. J. Cancer. 1996;66:464–469
  16. Franceschi S, Munoz N, Snijders PJ. How strong and how wide is the link between HPV and oropharyngeal cancer?. Lancet. 2000;356:871–872
  17. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, et al. Detection of Epstein–Barr virus in invasive breast cancers. J. Natl Cancer Inst. 1999;91:1376–1381
  18. Takada K. Epstein–Barr virus and gastric carcinoma. J. Clin. Pathol. 2000;53:255–261
  19. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, et al. DNA methylation environmental exposures in human hepatocellular carcinoma. J. Natl Cancer Inst. 2002;94:755–761
  20. Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am. J. Pathol. 2003;163:1101–1107
  21. Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, et al. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res. 2001;61:5727–5730
  22. Toyooka S, Carbone M, Toyooka KO, Bocchetta M, Shivapurkar N, Minna JD. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene. 2002;21:4340–4344
  23. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001;61:2799–2803
  24. Wu MF, Cheng YW, Lai JC, Hsu MC, Chen JT, Chiou MC, et al. Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan. Int. J. Cancer. 2005;113(3):440–445
  25. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 1999;27:2291–2298
  26. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003;349:2042–2054
  27. Ehrlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin. Immunol. 2003;109:17–28
  28. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99:247–257
  29. Fournel M, Sapieha P, Beaulieu N, Besterman JM, MacLeod AR. Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J. Biol. Chem. 1999;274:24250–24256
  30. Rhee I, Jair KW, Yen RW, Lengauer C, Herman JG, Kinzler KW, et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature. 2000;404:1003–1007
  31. Beaulieu N, Morin S, Chute IC, Robert MF, Nguyen H, MacLeod AR. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J. Biol. Chem. 2002;277:28176–28181
  32. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel K, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416:552–556
  33. Leu YW, Rahmatpanah F, Shi H, Wei SH, Liu JC, Yan PS, et al. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res. 2003;63:6110–6115
  34. Soejima K, Fang W, Rollins BJ. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene. 2003;22:4723–4733

PII: S0304-3835(04)00984-X

doi: 10.1016/j.canlet.2004.12.031

Cancer Letters
Volume 226, Issue 1 , Pages 77-84 , 8 August 2005